SCAI/HRS Expert Consensus Statement on Transcatheter Left Atrial Appendage Closure

Jacqueline Saw; David R. Holmes; João L. Cavalcante; James V. Freeman; Andrew M. Goldsweig; Clifford J. Kavinsky; Issam D. Moussa; Thomas M. Munger; Matthew J. Price; Mark Reisman; Matthew William Sherwood; Zoltan G. Turi; Dee Dee Wang; Brian K. Whisenant

doi:10.1016/j.jcin.2023.01.011

SCAI/HRS Expert Consensus Statement on Transcatheter Left Atrial Appendage Closure

Jacqueline Saw, David R. Holmes, João L. Cavalcante, James V. Freeman, Andrew M. Goldsweig, Clifford J. Kavinsky, Issam D. Moussa, Thomas M. Munger, Matthew J. Price, Mark Reisman, Matthew William Sherwood, Zoltan G. Turi, Dee Dee Wang, Brian K. Whisenant

Cardiovascular Medicine

Research output: Contribution to journal › Article › peer-review

Abstract

Exclusion of the left atrial appendage to reduce thromboembolic risk related to atrial fibrillation was first performed surgically in 1949. Over the past 2 decades, the field of transcatheter endovascular left atrial appendage closure (LAAC) has rapidly expanded, with a myriad of devices approved or in clinical development. The number of LAAC procedures performed in the United States and worldwide has increased exponentially since the Food and Drug Administration approval of the WATCHMAN (Boston Scientific) device in 2015. The Society for Cardiovascular Angiography & Interventions (SCAI) has previously published statements in 2015 and 2016 providing societal overview of the technology and institutional and operator requirements for LAAC. Since then, results from several important clinical trials and registries have been published, technical expertise and clinical practice have matured over time, and the device and imaging technologies have evolved. Therefore, SCAI prioritized the development of an updated consensus statement to provide recommendations on contemporary, evidence-based best practices for transcatheter LAAC focusing on endovascular devices.

Original language	English (US)
Pages (from-to)	1384-1400
Number of pages	17
Journal	JACC: Cardiovascular Interventions
Volume	16
Issue number	11
DOIs	https://doi.org/10.1016/j.jcin.2023.01.011
State	Published - Jun 12 2023

Keywords

CHADS-VASc
device-related thrombus
embolic stroke prevention
left atrial appendage closure
non-valvular atrial fibrillation
peridevice leak

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine

Access to Document

10.1016/j.jcin.2023.01.011

Cite this

Saw, J., Holmes, D. R., Cavalcante, J. L., Freeman, J. V., Goldsweig, A. M., Kavinsky, C. J., Moussa, I. D., Munger, T. M., Price, M. J., Reisman, M., Sherwood, M. W., Turi, Z. G., Wang, D. D., & Whisenant, B. K. (2023). SCAI/HRS Expert Consensus Statement on Transcatheter Left Atrial Appendage Closure. JACC: Cardiovascular Interventions, 16(11), 1384-1400. https://doi.org/10.1016/j.jcin.2023.01.011

Saw, J, Holmes, DR, Cavalcante, JL, Freeman, JV, Goldsweig, AM, Kavinsky, CJ, Moussa, ID, Munger, TM, Price, MJ, Reisman, M, Sherwood, MW, Turi, ZG, Wang, DD & Whisenant, BK 2023, 'SCAI/HRS Expert Consensus Statement on Transcatheter Left Atrial Appendage Closure', JACC: Cardiovascular Interventions, vol. 16, no. 11, pp. 1384-1400. https://doi.org/10.1016/j.jcin.2023.01.011

@article{392f378685d647a681a9d0fc9b984990,

title = "SCAI/HRS Expert Consensus Statement on Transcatheter Left Atrial Appendage Closure",

abstract = "Exclusion of the left atrial appendage to reduce thromboembolic risk related to atrial fibrillation was first performed surgically in 1949. Over the past 2 decades, the field of transcatheter endovascular left atrial appendage closure (LAAC) has rapidly expanded, with a myriad of devices approved or in clinical development. The number of LAAC procedures performed in the United States and worldwide has increased exponentially since the Food and Drug Administration approval of the WATCHMAN (Boston Scientific) device in 2015. The Society for Cardiovascular Angiography & Interventions (SCAI) has previously published statements in 2015 and 2016 providing societal overview of the technology and institutional and operator requirements for LAAC. Since then, results from several important clinical trials and registries have been published, technical expertise and clinical practice have matured over time, and the device and imaging technologies have evolved. Therefore, SCAI prioritized the development of an updated consensus statement to provide recommendations on contemporary, evidence-based best practices for transcatheter LAAC focusing on endovascular devices.",

keywords = "CHADS-VASc, device-related thrombus, embolic stroke prevention, left atrial appendage closure, non-valvular atrial fibrillation, peridevice leak",

author = "Jacqueline Saw and Holmes, {David R.} and Cavalcante, {Jo{\~a}o L.} and Freeman, {James V.} and Goldsweig, {Andrew M.} and Kavinsky, {Clifford J.} and Moussa, {Issam D.} and Munger, {Thomas M.} and Price, {Matthew J.} and Mark Reisman and Sherwood, {Matthew William} and Turi, {Zoltan G.} and Wang, {Dee Dee} and Whisenant, {Brian K.}",

note = "Publisher Copyright: {\textcopyright} 2023 Society for Cardiovascular Angiography and Interventions Foundation, Heart Rhythm Society and American College of Cardiology",

year = "2023",

month = jun,

day = "12",

doi = "10.1016/j.jcin.2023.01.011",

language = "English (US)",

volume = "16",

pages = "1384--1400",

journal = "JACC: Cardiovascular Interventions",

issn = "1936-8798",

publisher = "Elsevier Inc.",

number = "11",

}

TY - JOUR

T1 - SCAI/HRS Expert Consensus Statement on Transcatheter Left Atrial Appendage Closure

AU - Saw, Jacqueline

AU - Holmes, David R.

AU - Cavalcante, João L.

AU - Freeman, James V.

AU - Goldsweig, Andrew M.

AU - Kavinsky, Clifford J.

AU - Moussa, Issam D.

AU - Munger, Thomas M.

AU - Price, Matthew J.

AU - Reisman, Mark

AU - Sherwood, Matthew William

AU - Turi, Zoltan G.

AU - Wang, Dee Dee

AU - Whisenant, Brian K.

PY - 2023/6/12

Y1 - 2023/6/12

N2 - Exclusion of the left atrial appendage to reduce thromboembolic risk related to atrial fibrillation was first performed surgically in 1949. Over the past 2 decades, the field of transcatheter endovascular left atrial appendage closure (LAAC) has rapidly expanded, with a myriad of devices approved or in clinical development. The number of LAAC procedures performed in the United States and worldwide has increased exponentially since the Food and Drug Administration approval of the WATCHMAN (Boston Scientific) device in 2015. The Society for Cardiovascular Angiography & Interventions (SCAI) has previously published statements in 2015 and 2016 providing societal overview of the technology and institutional and operator requirements for LAAC. Since then, results from several important clinical trials and registries have been published, technical expertise and clinical practice have matured over time, and the device and imaging technologies have evolved. Therefore, SCAI prioritized the development of an updated consensus statement to provide recommendations on contemporary, evidence-based best practices for transcatheter LAAC focusing on endovascular devices.

AB - Exclusion of the left atrial appendage to reduce thromboembolic risk related to atrial fibrillation was first performed surgically in 1949. Over the past 2 decades, the field of transcatheter endovascular left atrial appendage closure (LAAC) has rapidly expanded, with a myriad of devices approved or in clinical development. The number of LAAC procedures performed in the United States and worldwide has increased exponentially since the Food and Drug Administration approval of the WATCHMAN (Boston Scientific) device in 2015. The Society for Cardiovascular Angiography & Interventions (SCAI) has previously published statements in 2015 and 2016 providing societal overview of the technology and institutional and operator requirements for LAAC. Since then, results from several important clinical trials and registries have been published, technical expertise and clinical practice have matured over time, and the device and imaging technologies have evolved. Therefore, SCAI prioritized the development of an updated consensus statement to provide recommendations on contemporary, evidence-based best practices for transcatheter LAAC focusing on endovascular devices.

KW - CHADS-VASc

KW - device-related thrombus

KW - embolic stroke prevention

KW - left atrial appendage closure

KW - non-valvular atrial fibrillation

KW - peridevice leak

UR - http://www.scopus.com/inward/record.url?scp=85159051522&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85159051522&partnerID=8YFLogxK

U2 - 10.1016/j.jcin.2023.01.011

DO - 10.1016/j.jcin.2023.01.011

M3 - Article

C2 - 36990858

AN - SCOPUS:85159051522

SN - 1936-8798

VL - 16

SP - 1384

EP - 1400

JO - JACC: Cardiovascular Interventions

JF - JACC: Cardiovascular Interventions

IS - 11

ER -

SCAI/HRS Expert Consensus Statement on Transcatheter Left Atrial Appendage Closure

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this